SB00051Introduced in the Senate
An Act Concerning The Research And Development Tax Credit Exchange Rate For Biotechnology Companies.
IntroducedJoint Finance, Revenue and Bonding
Introduced by Heather Bond Somers, District 18
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
To increase the research and development tax credit exchange rate under section 12-217ee of the general statutes to one hundred per cent for biotechnology companies.
Where it stands
Referred to Joint Committee on Finance, Revenue and Bonding
February 4, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
Referred to Joint Committee on Finance, Revenue and Bonding
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.